World's Best Scientists 2026 revealed!
Award Badge
Immunology
UK
2026
Award Badge
Medicine
UK
2026

D-Index & Metrics

Immunology

D-Index
157
Citations
108299
World Ranking
92
National Ranking
6

Medicine

D-Index
158
Citations
110121
World Ranking
837
National Ranking
88

Research.com Recognitions

  • 2026 - Research.com Immunology in United Kingdom Leader Award
  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Immunology in United Kingdom Leader Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

David A. Isenberg is affiliated with University College London in the United Kingdom. Their research primarily focuses on the field of Medicine, with significant contributions in Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, and Genetics.

Their recent scholarly publications include the following works:

  • "2021 DORIS definition of remission in SLE: final recommendations from an international task force" (2021), published in Lupus Science & Medicine
  • "Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis" (2020), published in Journal of Thrombosis and Haemostasis
  • "16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends" (2020), published in Lupus
  • "Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial" (2021), published in Arthritis & Rheumatology
  • "British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy" (2022), published by Lara D. Veeken

The scientist has frequently collaborated with the following co-authors:

  • Anisur Rahman
  • Caroline Gordon
  • Ian N Bruce
  • Michelle Petri
  • Cynthia Aranow

Their publications have appeared regularly in several academic venues, with notable frequency in:

  • Lara D. Veeken
  • Annals of the Rheumatic Diseases
  • UNC Libraries
  • Poster presentations
  • Lupus

The research topics addressed by David A. Isenberg encompass:

  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Atherosclerosis and Cardiovascular Diseases
  • T-cell and B-cell Immunology
  • Chronic Lymphocytic Leukemia Research
  • Systemic Sclerosis and Related Diseases
  • Lymphoma Diagnosis and Treatment

David A. Isenberg has been awarded the title of Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

    Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon

  • The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

    Dafna Gladman;Ellen Ginzler;Charles Goldsmith;Paul Fortin

  • The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

    Matthew H. Liang;Michael Corzillius;Sang Cheol Bae;Robert A. Lew

  • Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

    Claudio Vitali;Stefano Bombardieri;Haralampos M. Moutsopoulos;Genesio Balestrieri

  • Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus: The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial

    Joan T. Merrill;C. Michael Neuwelt;Daniel J. Wallace;Joseph C. Shanahan

  • CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

    Paul A. Blair;Lina Yassin Noreña;Fabian Flores-Borja;David J. Rawlings

  • Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

    Michael R. Ehrenstein;Jamie G. Evans;Animesh Singh;Samantha Moore

  • Mortality in systemic lupus erythematosus.

    S. Bernatsky;J. F. Boivin;L. Joseph;S. Manzi

  • Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

    Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler

  • Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer

  • EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

    G. Bertsias;J. P. A. Ioannidis;J. Boletis;S. Bombardieri

  • Systemic Lupus Erythematosus

    Caroline Gordon;Caroline Gordon;Caroline Gordon;Charles K. Li;Charles K. Li;Charles K. Li;David A. Isenberg;David A. Isenberg;David A. Isenberg

  • EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    G K Bertsias;J P A Ioannidis;M Aringer;E Bollen

  • Systemic lupus erythematosus.

    Larissa Lisnevskaia;Grainne Murphy;David Isenberg

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.

    Tak Mao Chan;Fu Keung Li;Colin S.O. Tang;Raymond W.S. Wong

  • The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

    E.M. Hay;P.A. Bacon;C. Gordon;D.A. Isenberg

  • BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

    D. A. Isenberg;A. Rahman;E. Allen;V. Farewell

  • Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial

    Ernest Choy;D A Isenberg;Toby Garrood;S Farrow

  • The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.

    Dafna D. Gladman;Murray B. Urowitz;Charles H. Goldsmith;Paul Fortin

  • An open study of B lymphocyte depletion in systemic lupus erythematosus

    Maria J. Leandro;Jonathan C. Edwards;Geraldine Cambridge;Michael R. Ehrenstein

Frequent Co-Authors

Caroline Gordon
Caroline Gordon University of Birmingham
Ian N. Bruce
Ian N. Bruce University of Manchester
Michelle Petri
Michelle Petri Johns Hopkins University School of Medicine
Murray B. Urowitz
Murray B. Urowitz University of Toronto
Munther A. Khamashta
Munther A. Khamashta King's College London
Paul R. Fortin
Paul R. Fortin Université Laval
Rosalind Ramsey-Goldman
Rosalind Ramsey-Goldman Northwestern University
Daniel J. Wallace
Daniel J. Wallace Cedars-Sinai Medical Center
Ann E. Clarke
Ann E. Clarke University of Calgary
Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens various doors to healthcare professions, with many students exploring related nursing and clinical fields. For those considering a swift transition into nursing, accelerated fnp programs offer an efficient pathway to becoming a Family Nurse Practitioner. These programs are designed for those looking to advance quickly while gaining specialized skills.

If you're starting without a nursing background, several options can help you enter the field. Notably, the best online bsn programs for non nurses provide flexibility for individuals seeking a Bachelor of Science in Nursing (BSN) remotely. These programs accommodate busy schedules and diverse learning styles.

For students eager to complete their education within a shorter timeframe, 12-month accelerated nursing programs present an appealing option. These intensive courses help candidates quickly qualify for nursing roles while maintaining quality education standards.

Additionally, those interested in practical nursing roles might explore easy admission lpn programs. Licensed Practical Nurse (LPN) programs with straightforward admissions can serve as a stepping stone for a healthcare career and provide valuable hands-on experience.

Best Scientists Citing David A. Isenberg

Trending Scientists